Sherman Mark E, Devesa Susan S
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, Maryland 20892, USA.
Cancer. 2003 Jul 1;98(1):176-86. doi: 10.1002/cncr.11484.
In the United States, incidence rates for malignant tumors of the uterine corpus are lower among blacks than among whites, whereas mortality rates are higher among blacks. Reasons for the higher level of mortality among blacks have been debated.
Using data from the Surveillance, Epidemiology, and End Results program, the authors compared incidence rates by histopathologic type for malignant tumors of the uterine corpus (including uterus, not otherwise specified) during the period 1992-1998 among white Hispanic, black, and white non-Hispanic patients. The authors also compared cumulative relative survival rates for blacks and whites by histopathologic type and by other factors, and they calculated estimated type-specific mortality rates.
Overall incidence (per 100,000 woman-years) of corpus malignancy was significantly lower among white Hispanics (14.04; 95% confidence interval [CI], 13.39-14.72) and blacks (15.31; 95% CI, 14.61-16.04) compared with white non-Hispanics (23.43; 95% CI, 23.06-23.81). Compared with white non-Hispanics, blacks had significantly higher incidence rates of serous/clear cell carcinoma (rate ratio, 1.85; 95% CI, 1.61-2.12), carcinosarcoma (rate ratio, 2.33; 95% CI, 1.99-2.72), and sarcoma (rate ratio, 1.56; 95% CI, 1.31-1.86). Survival was worse for blacks than for whites in every histopathologic category and in 'usual' types of endometrial adenocarcinoma, stratified by stage, grade, and age. Rare aggressive tumor types accounted for 53% of mortality among blacks, compared with 36% among whites.
Less favorable outcomes for usual types of endometrial adenocarcinoma and for rare aggressive tumors contribute equally to the relatively high mortality due to corpus cancer among black women.
在美国,黑人子宫体恶性肿瘤的发病率低于白人,而死亡率则高于白人。黑人死亡率较高的原因一直存在争议。
作者利用监测、流行病学和最终结果计划的数据,比较了1992 - 1998年期间西班牙裔白人、黑人以及非西班牙裔白人患者子宫体恶性肿瘤(包括未另作说明的子宫)按组织病理学类型划分的发病率。作者还比较了黑人和白人按组织病理学类型及其他因素划分的累积相对生存率,并计算了特定类型的估计死亡率。
与非西班牙裔白人(23.43;95%置信区间[CI],23.06 - 23.81)相比,西班牙裔白人(14.04;95% CI,13.39 - 14.72)和黑人(15.31;95% CI,14.61 - 16.04)的子宫体恶性肿瘤总体发病率(每100,000人年)显著较低。与非西班牙裔白人相比,黑人浆液性/透明细胞癌(发病率比值,1.85;95% CI,1.61 - 2.12)、癌肉瘤(发病率比值,2.33;95% CI,1.99 - 2.72)和肉瘤(发病率比值,1.56;95% CI,1.31 - 1.86)的发病率显著更高。在每个组织病理学类别以及按分期、分级和年龄分层的“常见”子宫内膜腺癌类型中,黑人的生存率均低于白人。罕见的侵袭性肿瘤类型在黑人死亡率中占53%,而在白人中占36%。
常见类型的子宫内膜腺癌和罕见的侵袭性肿瘤预后较差,这同样导致了黑人女性因子宫体癌而相对较高的死亡率。